Mental training program helps ease chemobrain in breast cancer
the ONA take:
A new program developed by UCLA researchers may ease post-treatment cognitive difficulties, better known as “chemo brain”, in patients with breast cancer, according to a study published in Psycho-Oncology.
In a randomized clinical trial, researchers led by Patricia Ganz, MD, built upon prior research that found a connection between neuro-psychological test performance and memory complaints in women being treated for early-stage breast cancer.
“We invited the women to participate in a research study that assigned them to early or delayed treatment with a five-week, two-hour group training session, where a psychologist taught them strategies to help them with their memory and maintaining their ability to pay attention to things,” Dr. Ganz said.
All the women who enrolled completed questions about their mood and mental functioning in follow-up testing.
Ganz and her fellow researchers found that women in the early intervention group reported improvements in memory complaints and test functioning, while those in the delayed group did not improve in either category.
“We hope that this might be an effective biologic way to assess the cognitive effects of cancer treatment in the future.”
A new program developed by UCLA researchers may ease post-treatment “chemo brain” in patients with breast cancer.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|